Back to Authors

Sandroni, Paula

https://orcid.org/0009-0000-4208-1230

Mayo Clinic

WinnMed

Citations 2

Management of erythromelalgia: a narrative review and expert opinion
Aldhalaan, Jumana , Sartori-Valinotti, Julio C., Davis, Mark D.P. , Sandroni, Paula , Davis, Mark Denis P., Sartori‐Valinotti, Julio C. , Sandroni, Paola

Expert Opinion on Pharmacotherapy | September 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-12

10.1080/14656566.2026.2734121 Get It

Clinical and Pathological Features of CSF1R-Related Disorder Associated With the p.R777Q Pathogenic Variant
Chmiela, Tomasz , Liskey, Delaney , Strongosky, Audrey , McCarter, Stuart J. , Sandroni, Paula , Dickson, Dennis W. , Wszołek, Zbigniew K. , Wszolek, Z.K. , Strongosky, Audrey J, Chmiela, Tomasz , Dickson, Dennis W , McCarter, Stuart J , Strongosky, Audrey J , Sandroni, Paula

Journal of Movement Disorders | November 14, 2025 | Volume: 19 | Issue: 2 | Pages: 135-144

10.14802/jmd.25247 Get It

Objective Colony-stimulating factor-1 receptor (<i>CSF1R</i>)-related disorder (CSF1R-RD) is a rapidly progressive neurodegenerative disease with a median onset of 43 years. More than 200 <i>CSF1R</i> pathogenic variants have been identified. Patients develop rapidly progressive dementia and motor symptoms, with a median disease duration of 6.8 years. The p.R777Q variant causes CSF1R-RD; it is deleterious to protein function. We describe the clinical and pathological features of CSF1R-RD associated with p.R777Q and report a new family carrying this variant. We compare the neuropathological findings of an index patient (with short-duration disease) with those of a patient with long-duration CSF1R-RD.Methods We present clinical and imaging data from a new family with p.R777Q. We also describe the neuropathology of an index patient and contrast these findings with features of a patient with CSF1R-RD with an 11-year disease course caused by the c.2656_2657insC variant.Results We reviewed the literature on 13 individuals from 8 families with the p.R777Q variant from Asia, Europe, and North America. The mean age at onset was 41±14 years, ranging from 22 to 63 years, and the mean survival was 3.3±2.5 years. Neuropathologic studies of our index patient (10-month disease duration) revealed features consistent with CSF1R-RD. Axonal and myelin pathology was severe in the periventricular white matter. Compared with the patient with an 11-year disease duration, the index patient had less severe white matter lesions.Conclusion Compared with CSF1R-RD associated with other variants, the p.R777Q variant has an aggressive course. Compared with the patient with a long disease duration, the index patient had milder neuropathological findings. These differences may be specific to p.R777Q or associated with rapid clinical progression.